Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.343SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-18611Singapore
EG.1.5SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-18611Singapore
B.1.264.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18617.7China
FU.2.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-18622.3Singapore
BQ.1.25.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
BQ.1.25SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
BA.5.2.59SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
B.1.1.53SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
BQ.1.30SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
CH.1.1.30SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
CH.1.1.18SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
XBRSChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-18625.1China
C.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
EE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
EE.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
EE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
BQ.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
EE.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
EE.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
FL.30.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-18641.9Japan
FL.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-18648.1South Korea
FL.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-18648.1South Korea
AY.104 (Delta)ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-18656.8China
B.1.1.406NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
B.1.1.265NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
FY.8.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
XBB.2.3.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
EG.5.1.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
CH.1.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
CH.1.1.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
LB.1.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18664.8Thailand
B.1.214.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.210NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.399NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
BB.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.630NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.621 (Mu)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.280NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.637NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.427 (Epsilon)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.429 (Epsilon)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.621.1 (Mu)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.375NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.433NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.605NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.139NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.518NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.111NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.619NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
B.1.214NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18666.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used